Copyright
©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 7, 2005; 11(41): 6429-6432
Published online Nov 7, 2005. doi: 10.3748/wjg.v11.i41.6429
Published online Nov 7, 2005. doi: 10.3748/wjg.v11.i41.6429
VP22 fusion protein-based dominant negative mutant can inhibit hepatitis B virus replication
Jun Yi, Ling Wang, Rui Ling, Jiang-Hao Chen, Jun Yun, Department of General Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710033, Shaanxi Province, China
Wei-Dong Gong, Oncology Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China, No. 30400380
Correspondence to: Wei-Dong Gong, Oncology Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510282, Guangdong Province, China. gongwd70@fmmu.edu.cn.
Telephone: +86-20-83373939
Received: December 2, 2004
Revised: February 15, 2005
Accepted: February 18, 2005
Published online: November 7, 2005
Revised: February 15, 2005
Accepted: February 18, 2005
Published online: November 7, 2005
Core Tip